7 7 2 5 8

论文已发表


注册即可获取德孚的最新动态



IF 收录期刊





更多详情 >>



作者优惠计划

Favored Author Program


很高兴为我们的作者提供一种切实的方法以支持开放获取,并鼓励教师和研究人员通过开放获取模式,尽可能广泛地推广他们的作品。


作者优惠计划的成员将获得:


文章发表费(APC) 10% 的折扣


这 10% 的折扣从您加入 “作者优惠计划” 之时开始,并将适用于之后提交的所有论文



*若要加入“作者优惠计划”,您需要已经在德孚医药出版社发表过论文,或为我们进行过同行评审。作者必须在提交论文之前注册该优惠计划,折扣不能追溯应用于已提交的论文




更多详情 >>



已发表论文

微波消融治疗伴丙型肝炎病毒感染的淋巴上皮瘤样胆管癌:文献综述和病例报告

 

Authors Li X, Ji H, Zhang D, Jin M, Guo X, Gao P

Received 14 March 2022

Accepted for publication 18 June 2022

Published 4 July 2022 Volume 2022:14 Pages 2155—2160

DOI https://doi.org/10.2147/CMAR.S366419

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Beicheng Sun

Background: Lymphoepithelioma-like cholangiocarcinoma (LELCC) is a rare type of intrahepatic tumor that is poorly understood. It is not associated with specific physical findings and is usually diagnosed incidentally, resulting in tumors that are often large-sized at diagnosis. At present, the main treatment approach is surgical resection.
Case Presentation: Here, we report the case of a patient with LELCC treated with microwave ablation (MWA). Our patient was a Chinese man with chronic hepatitis C and a 51 mm-diameter intrahepatic tumor. Despite blood testing, gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging, and abdominal ultrasound, the tumor was not well diagnosed. However, the histopathological findings of ultrasound-guided percutaneous tumor biopsy led to a diagnosis of LELCC. The patient was treated with MWA, and no new lesions had occurred at 9 months after treatment.
Conclusion: To our knowledge, this is the first patient with LELCC treated using MWA. Our experience suggests that MWA is an effective new therapeutic method for this disease.
Keywords: Epstein-Barr virus, lymphoepithelioma-like cholangiocarcinoma, microwave ablation, hepatitis C, liver tumor